INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Regeneron Pharmaceuticals, Inc. - REGN
Portfolio Pulse from
Pomerantz Law Firm has filed a class action lawsuit against Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Investors are advised to contact the firm for more information.
February 28, 2025 | 1:15 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
A class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. by Pomerantz Law Firm. This legal action could potentially impact the company's stock price.
The filing of a class action lawsuit against Regeneron Pharmaceuticals is likely to have a negative impact on its stock price in the short term due to potential legal liabilities and investor concerns.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100